VolitionRX Q3 EPS $(0.21) Beats $(0.40) Estimate, Sales $1.614M Beat $706.500K Estimate
Benzinga Newsdesk 17 hours ago
NewsEarningsEarnings Beats
VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.40) by 47.5 percent. This is a 79 percent increase over losses of $(1.00) per share from the same
VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.40) by 47.5 percent. This is a 79 percent increase over losses of $(1.00) per share from the same period last year. The company reported quarterly sales of $1.614 million which beat the analyst consensus estimate of $706.500 thousand by 128.43 percent. This is a 157.28 percent increase over sales of $627.277 thousand the same period last year.